4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-21-055368
Chief Financial Officer sold 14,375 shares at an average $39.47 ($567,331)
- Chief Financial Officer acquired 14,375 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Cohen Chad M · Chief Financial Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-09-07 | Exercise or conversion : show line 1 in the form | +9,375 | $6.55 | $61,406 | 30,979 | D |
| 2021-09-07 | Sale : show line 2 in the form | −9,375 | $39.71 | $372,281 | 21,604 | D |
| 2021-09-08 | Exercise or conversion : show line 3 in the form | +5,000 | $7.27 | $36,350 | 26,604 | D |
| 2021-09-08 | Sale : show line 4 in the form | −5,000 | $39.01 | $195,050 | 21,604 | D |
| Open-market sales · 14,375 sh · avg $39.47 · $567,331 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-09-07 | Exercise or conversion : show line 5 in the form Stock Option (Right to Buy) | −9,375 | 65,625 | D |
| 2021-09-08 | Exercise or conversion : show line 6 in the form Stock Option (Right to Buy) | −5,000 | 110,000 | D |
Loading xslF345X03/doc4.xml…